biotechnology

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

Just two years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has already established

Healthvana’s digital COVID-19 vaccination records are about communication, not passports for the immune

As the vaccination campaign to counter COVID-19 gets underway (albeit with a rocky start), a number of companies are attempting to support its rollout in a variety of ways. Healthvana, a health tech s

Senti Bio raises $105 million for its new programmable biology platform and cancer therapies

Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences

Poland’s GeneMe secures €5.2M seed funding for its rapid COVID-19 test

GeneMe, Poland-based biotechnology company with a COVID-19 test, has secured a €5.2 million round of seed funding led by Robin Tombs, co-founder of Yoti and previously of Gamesys, and other angel in

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

Resilience, a new biopharmaceutical company backed by $800 million in financing from investors including ARCH Venture Partners and 8VC, has emerged from stealth to transform the way that drugs and the

Daily Crunch: Amazon unveils its own game-streaming platform

Amazon announces a new game service and plenty of hardware upgrades, tech companies team up against app stores and United Airlines tests a program for rapid COVID-19 testing. This is your Daily Crunch

Does early-stage health tech need more ‘patient’ capital?

Crista Galli Ventures, a new early-stage health tech fund in Europe, officially launched last week. The firm offers “patient capital” — with only a single LP (the Danish family office IPQ Capita

Alternative protein companies have raised a whopping $1.5 billion through July of this year

Companies like Perfect Day, Impossible Foods and a host of other startups that are developing replacements for animal-farmed goods used in food, clothes, cosmetics and chemicals have raised a whopping

Synthetic biology startups are giving investors an appetite

There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi

Mammoth Biosciences’s CRISPR-based COVID-19 test receives NIH funding through RADx program

CRISPR tech startup Mammoth Biosciences is among the companies that revealed backing from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) program on Friday. Mammoth re

Bit Bio’s ‘enter button for the keyboard to the software of life’ nabs the company $41.5 million

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery

Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuti

Intel has invested $132M in 11 startups this year, on track for $300M-$500M in total

When it comes to corporate venture capital, semiconductor giant Intel has shaped up to be one of the most prolific and prescient investors in the tech world, with investments in 1,582 companies worl

NEA-backed Personal Genome Diagnostics receives FDA clearance for its cancer diagnostic

Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Admin

Curative received FDA emergency use authorization for its novel COVID-19 tests

The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests h

Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test

SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. Th

Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech

Flagship Pioneering, the Boston-based biotech incubator and holding company, said it has raised $1.1 billion for its Flagship Labs unit. Flagship, which raised $1 billion back in 2019 for growth-stage

ARCH Venture Partners raises $1.46 billion across two funds for biotech investing

Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life scie

Aspen Neuroscience raises $70M for its experimental Parkinson’s Disease treatment

Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for Parkinson Disease. No

Cell and gene therapy startup ElevateBio raises $170M

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant mone
Load More